{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:53:33Z","timestamp":1791359613754,"version":"4.3.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Institute for Information & Communications Technology Promotion","award":["RS-2024-00509279"],"award-info":[{"award-number":["RS-2024-00509279"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11060-026-05742-w","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:37:30Z","timestamp":1787035050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Big data in U.S. neuro-oncology: trends and translational priorities"],"prefix":"10.1007","volume":"179","author":[{"given":"Anjali","family":"Kapoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Alyakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Markert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krithik","family":"Vishwanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Vivian","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sughrue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Karl","family":"Oermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"5742_CR1","doi-asserted-by":"crossref","unstructured":"Calabrese E, Villanueva-Meyer J, Rudie J et al (2022) The University of California San Francisco Preoperative Diffuse Glioma MRI (UCSF-PDGM)","DOI":"10.1148\/ryai.220058"},{"key":"5742_CR2","unstructured":"Chadha S, Weiss D, Janas A et al (2025) Yale longitudinal dataset of brain metastases on MRI with associated clinical data. Yale-Brain-Mets-Longitudinal"},{"key":"5742_CR3","unstructured":"BrainMetShare Dataset In: Center for Artificial Intelligence in Medicine & Imaging. https:\/\/aimi.stanford.edu\/datasets\/brainmetshare. Accessed 9 Mar 2026"},{"key":"5742_CR4","unstructured":"Brain Tumor Segmentation (BraTS) Challenge https:\/\/www.med.upenn.edu\/cbica\/brats\/. Accessed 27 Jan 2026"},{"key":"5742_CR5","doi-asserted-by":"crossref","unstructured":"Fateh A, Rezvani Y, Moayedi S et al (2025) BRISC: Annotated dataset for brain tumor segmentation and classification. arXiv [eess.IV]","DOI":"10.1038\/s41597-026-06753-y"},{"key":"5742_CR6","doi-asserted-by":"publisher","first-page":"8170","DOI":"10.1038\/s41467-024-52414-2","volume":"15","author":"KE Link","year":"2024","unstructured":"Link KE, Schnurman Z, Liu C et al (2024) Longitudinal deep neural networks for assessing metastatic brain cancer on a large open benchmark. Nat Commun 15:8170","journal-title":"Nat Commun"},{"key":"5742_CR7","unstructured":"The cancer genome atlas program (TCGA). (2022). https:\/\/www.cancer.gov\/ccg\/research\/genome-sequencing\/tcga. Accessed 27 Jan 2026"},{"key":"5742_CR8","unstructured":"Therapeutically applicable research to generate effective treatments (TARGET). (2022). https:\/\/www.cancer.gov\/ccg\/research\/genome-sequencing\/target. Accessed 27 Jan 2026"},{"key":"5742_CR9","unstructured":"Scarpace L, Flanders AE, Jain R et al (2019) Data from REMBRANDT"},{"key":"5742_CR10","unstructured":"Verhaak R Glioma Longitudinal AnalySiS (GLASS) Consortium. https:\/\/glass-consortium.org\/. Accessed 10 Mar 2026"},{"key":"5742_CR11","unstructured":"Children\u2019s Brain Tumor Network - United We Cure. (2025). In: Children\u2019s Brain Tumor Network - Accelerating childhood brain tumor research to faster cures. https:\/\/cbtn.org\/. Accessed 27 Jan 2026"},{"key":"5742_CR12","unstructured":"Cancer of the Brain and Other Nervous System - Cancer Stat Facts. In: SEER. https:\/\/seer.cancer.gov\/statfacts\/html\/brain.html. Accessed 19 Jan 2026"},{"key":"5742_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1108\/LR-06-2015-0061","volume":"65","author":"A De Mauro","year":"2016","unstructured":"De Mauro A, Greco M, Grimaldi M (2016) A formal definition of Big Data based on its essential features. Libr Rev 65:122\u2013135","journal-title":"Libr Rev"},{"key":"5742_CR14","unstructured":"Surveillance epidemiology, and end results program. In: SEER. https:\/\/seer.cancer.gov\/. Accessed 27 Jan 2026"},{"key":"5742_CR15","unstructured":"CBTRUS. (2019). In: CBTRUS. https:\/\/cbtrus.org\/. Accessed 27 Jan 2026"},{"key":"5742_CR16","unstructured":"AACR Project GENIE(R): Powering Precision Medicine. (2019) In: American Association for Cancer Research (AACR). https:\/\/www.aacr.org\/professionals\/research\/aacr-project-genie\/. Accessed 27 Jan 2026"},{"key":"5742_CR17","unstructured":"CancerLinQ (2026) https:\/\/www.cancerlinq.org\/. Accessed 27 Jan"},{"key":"5742_CR18","unstructured":"Home In: Children\u2019s Oncology Group (COG). https:\/\/childrensoncologygroup.org\/. Accessed 10 Mar 2026"},{"key":"5742_CR19","unstructured":"Pediatric Brain Tumor Consortium (2026) https:\/\/www.pbtc.org\/. Accessed 27 Jan"},{"key":"5742_CR20","unstructured":"Home: (2026) Ivy Glioblastoma Atlas Project. https:\/\/glioblastoma.alleninstitute.org\/. Accessed 10 Mar"},{"key":"5742_CR21","unstructured":"Translational Neuro-Oncology (2026) Jann N. Sarkaria - Overview. In: Mayo Clinic. https:\/\/www.mayo.edu\/research\/labs\/translational-neuro-oncology\/mayo-clinic-brain-tumor-patient-derived-xenograft-national-resource\/overview. Accessed 10 Mar"},{"key":"5742_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-026-04229-5","author":"SF Chen","year":"2026","unstructured":"Chen SF, Alyakin A, Seas A et al (2026) LLM-assisted systematic review of large language models in clinical medicine. Nat Med. https:\/\/doi.org\/10.1038\/s41591-026-04229-5","journal-title":"Nat Med"},{"key":"5742_CR23","doi-asserted-by":"publisher","first-page":"1037896","DOI":"10.3389\/fonc.2022.1037896","volume":"12","author":"M Waqar","year":"2022","unstructured":"Waqar M, Van Houdt PJ, Hessen E, Li KL, Zhu X, Jackson A, Iqbal M, O\u2019Connor J, Djoukhadar I, van der Heide UA, Coope DJ, Borst GR (2022) Visualising spatial heterogeneity in glioblastoma using imaging habitats. Front Oncol 12:1037896. https:\/\/doi.org\/10.3389\/fonc.2022.1037896","journal-title":"Front Oncol"},{"key":"5742_CR24","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/s41597-025-06068-4","volume":"12","author":"HK Nahal-Bose","year":"2025","unstructured":"Nahal-Bose HK, Lichter P, Weber U, Stein LD, Bajari R, Xiang L, Su E, Eubank J, Schutte C, Yung CK, Courtot M (2025) The ICGC ARGO data dictionary for standardizing global cancer clinical data. Sci Data 12:1852. https:\/\/doi.org\/10.1038\/s41597-025-06068-4","journal-title":"Sci Data"},{"issue":"2","key":"5742_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","volume":"27","author":"SL Cohn","year":"2009","unstructured":"Cohn SL, Pearson ADJ, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK, INRG Task Force (2009) The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 27(2):289\u2013297. https:\/\/doi.org\/10.1200\/JCO.2008.16.6785","journal-title":"J Clin Oncol"},{"issue":"4","key":"5742_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/jnci\/djaf242","volume":"118","author":"SL Cohn","year":"2025","unstructured":"Cohn SL, London WB, Schleiermacher G, Moreno L, Ambros IM, Ambros PF, Bagatell R, Beck Popovic M, Beiske KH, Berthold F, Birz S, Brisse HJ, Brodeur GM, Brock PR, Burchill S, Eggert A, Federico SM, Fischer M, Furner BT, Hero B, Machin D, Kamijo T, Matthay KK, Nakagawara A, Naranjo A, Potschger U, Valteau-Couanet D, Watkins MT, Irwin MS, Volchenboum SL, Park JR, Pearson ADJ (2025) International neuroblastoma risk group consortium: a model of networking for rare cancers. J Natl Cancer Inst 118(4):579\u2013588. https:\/\/doi.org\/10.1093\/jnci\/djaf242","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"5742_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1158\/1078-0432.CCR-17-0764","volume":"24","author":"BM Alexander","year":"2018","unstructured":"Alexander BM, Ba S, Berger MS, Berry DA, Cavenee WK, Chang SM, Cloughesy TF, Jiang T, Khasraw M, Li W, Mittman R, Poste GH, Wen PY, Yung WKA, Barker AD, GBM AGILE Network (2018) Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE. Clin Cancer Res 24(4):737\u2013743. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0764","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05742-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05742-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05742-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:34:53Z","timestamp":1791358493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05742-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5742"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05742-w","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EKO has equity in Delvi, MarchAI, and Artisight, income from Merck & Co. and Mirati Therapeutics, employment at Eikon Therapeutics, and consults for Sofinnova Partners and Google.","order":2,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"45"}}